Media Use, Anxiety, Sedation, and Recovery in Children Having Upper GI Endoscopy (PMU-ASR-ENDO)
Association Between Problematic Media Use and Preprocedural Anxiety, Sedation, and Recovery Outcomes in Children Undergoing Elective Upper Gastrointestinal Endoscopy: A Prospective Observational Cohort Study
This observational study will investigate whether problematic digital media use is associated with anxiety in children undergoing a planned upper gastrointestinal endoscopy, a camera examination of the upper digestive tract. The study hypothesis is that problematic media use is associated with the child's anxiety immediately before sedation. Associations with sedation medicine requirements and recovery after the procedure will also be explored.
The study will include 60 children aged 6 to 11 years. Parents or legal guardians will complete a questionnaire about their child's media use and provide information on screen time and viewing habits. An independent observer will assess anxiety at three time points: on arrival in the preparation area, before transfer to the procedure room, and immediately before sedation.
Researchers will record the medicines and doses used for sedation or anaesthesia, procedure duration, agitation during recovery, recovery time, readiness for discharge, and sedation-related adverse events. Endoscopy and sedation will be managed according to routine clinical practice.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Eligible children aged 6-11 years scheduled for elective diagnostic upper gastrointestinal endoscopy at the Pediatric Endoscopy Unit will be enrolled consecutively.
Description
Inclusion Criteria:
- Age 6-11 years; ASA I-II; scheduled for elective diagnostic upper GI endoscopy under sedation or general anesthesia.
- Turkish-speaking parent/legal representative able to report media use and complete forms; written consent and child assent.
Exclusion Criteria:
- Emergency or therapeutic endoscopy; concurrent colonoscopy/other procedure; ASA III-IV.
- Condition or communication difficulty preventing reliable mYPAS assessment.
- Regular sedative/antipsychotic use; unreliable media-use report; prior enrollment; incomplete PMU scale or essential data.
Antiepileptic use alone is not an exclusion criterion; the anesthesiologist will assess eligibility individually.
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Children Undergoing Elective Upper Gastrointestinal Endoscopy
|
Problematic media use will be assessed using the parent-reported 9-item PMKÖ-KF. Parents will rate the child's typical behavior during the preceding month on a 5-point scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always). The score will be calculated as the mean of the nine item responses (range: 1-5); higher scores indicate greater problematic media use. Media use will not be assigned or modified by investigators. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Yale Preoperative Anxiety Scale (mYPAS) scores
Time Frame: During the preprocedural assessment, before sedation and endoscopy.
|
The Modified Yale Preoperative Anxiety Scale (mYPAS) will be assessed at three time points: T1, upon admission to the preparation area; T2, immediately before transfer to the procedure room; and T3, immediately before sedation initiation. The mYPAS score (0-100) at T3 is the primary outcome and will be analyzed as a continuous variable. The association between the T3 mYPAS score and the PMKÖ-KF mean score (mean of nine items, range 1-5; higher scores indicate greater problematic media use) will be evaluated. |
During the preprocedural assessment, before sedation and endoscopy.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary Anxiety, Sedation, and Recovery Outcomes
Time Frame: From preparation-area admission through recovery-unit discharge.
|
Secondary outcomes include associations between media use and anxiety; sedative/anesthetic use and additional medication; procedure duration and completion; recovery agitation (Watcha Agitation Score); recovery status (Modified Aldrete Score); time to eye opening and discharge readiness; recovery-unit stay; and sedation-related adverse events. |
From preparation-area admission through recovery-unit discharge.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- bau_endoscopy_pediatric
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.